These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1113 related articles for article (PubMed ID: 32010188)

  • 21. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response.
    Chen L; Zhang D; Zheng S; Li X; Gao P
    Front Genet; 2022; 13():959834. PubMed ID: 36110210
    [No Abstract]   [Full Text] [Related]  

  • 22. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 23. A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma.
    Long J; Zhang L; Wan X; Lin J; Bai Y; Xu W; Xiong J; Zhao H
    J Cell Mol Med; 2018 Dec; 22(12):5928-5938. PubMed ID: 30247807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification and Validation of a Novel Tertiary Lymphoid Structures-Related Prognostic Gene Signature in Hepatocellular Carcinoma.
    Liu Y; Li CB; Zhai YP; Zhang SK; Li DY; Gao ZQ; Liang RP
    World J Oncol; 2024 Aug; 15(4):695-710. PubMed ID: 38993245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
    Zhang Y; Tang Y; Guo C; Li G
    Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.
    Chen W; Yang Z; Chen Y
    Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
    Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z
    PeerJ; 2020; 8():e9201. PubMed ID: 32518728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma.
    Li G; Zhang D; Liang C; Liang C; Wu J
    Front Oncol; 2022; 12():1021775. PubMed ID: 36338707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma.
    Xie H; Liu S; Zhang Z; Chen P; Tao Y
    J Cancer; 2020; 11(19):5768-5781. PubMed ID: 32913470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
    Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
    Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Dendritic Cell-Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis.
    Huang C; Jiang X; Huang Y; Zhao L; Li P; Liu F
    Front Mol Biosci; 2021; 8():636991. PubMed ID: 34109210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
    Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
    J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
    Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
    Front Oncol; 2021; 11():629327. PubMed ID: 33718205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
    Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X
    BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis.
    Zhu W; Ru L; Ma Z
    Front Oncol; 2021; 11():626654. PubMed ID: 33777771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma.
    Li G; Xu S; Yang S; Wu C; Zhang L; Wang H
    Front Genet; 2022; 13():1029576. PubMed ID: 36568382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.